Miguel, Isaac
Feliz, Edwin P.
Agramonte, Robinson
Martinez, Pedro V.
Vergara, Carlos
Imbert, Yvonne
De la Cruz, Lucia
de Castro, Nurys
Cedano, Odalis
De la Paz, Yamilka
Fonseca, Vagner
Santiago, Gilberto A.
Muñoz-Jordán, Jorge L.
Peguero, Armando
Paulino-Ramírez, Robert
Grubaugh, Nathan D.
de Filippis, Ana Maria Bispo
Alcantara, Luiz Carlos Junior
Rico, Jairo Mendez
Lourenço, José
Franco, Leticia
Giovanetti, Marta
Funding for this research was provided by:
ICGEB (CRP/BRA20-03)
Article History
Received: 12 March 2024
Accepted: 24 July 2024
First Online: 29 July 2024
Declarations
:
: The Pan American Health Organization Ethics Review Committee (PAHOERC) thoroughly reviewed and approved our project (IRB Ref. No. PAHO-2016–08-0029). The samples utilized were de-identified residual samples obtained from routine arbovirus diagnoses conducted at the public health laboratory in the Dominican Republic, which is an integral component of the country's Ministry of Health public network. It's important to note that informed consent was not required as the samples used were residual specimens collected for diagnostic screening at the Reference Laboratory of Health in Santo Domingo. Consequently, the Pan American Health Organization (PAHO) has authorized under the terms of the 510/2016 Resolution the utilization of clinical samples collected at the Central Public Health Laboratory without the need for informed consent. This decision aims to expedite knowledge acquisition and enhance surveillance and response efforts during outbreaks.
: Not applicable.
: Conflict of interests Nathan D. Grubaugh (NDG) is a paid consultant for BioNTech. All other authors declare that there are no conflicts of interests.